NCT07020988View on ClinicalTrials.gov

A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 12, 2025

Primary Completion Date

January 29, 2026

Study Completion Date

January 29, 2026

Conditions
Healthy Participants
Interventions
DRUG

Staccato Alprazolam

Study participants will receive single dose of Staccato Alprazolam at pre-specified time points.

DRUG

Midazolam

Study participants will receive single dose of IV Midazolam at pre-specified time points.

DRUG

Diazepam

Study participants will receive single dose of Nasal Diazepam by inhalation at pre-specified time points.

Trial Locations (1)

91206

RECRUITING

Up0127 1001, Glendale

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY